Chronic kidney disease, cardiovascular risk markers and total mortality in older men: cystatin C versus creatinine | Zendy

Shahrzad Zonoozi | Zendy; Sheena E Ramsay | Zendy; Olia Papacosta | Zendy; Lucy Len | Zendy; Elizabeth A. Ellins | Zendy; Julian Halcox | Zendy; Peter H. Whincup | Zendy; S. Goya Wannamethee | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Chronic kidney disease, cardiovascular risk markers and total mortality in older men: cystatin C versus creatinine

Author(s) -

Shahrzad Zonoozi,

Sheena E Ramsay,

Olia Papacosta,

Lucy Len,

Elizabeth A. Ellins,

Julian Halcox,

Peter H. Whincup,

S. Goya Wannamethee

Publication year - 2019

Publication title -

journal of epidemiology and community health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.692

H-Index - 170

eISSN - 1470-2738

pISSN - 0143-005X

DOI - 10.1136/jech-2018-211719

Subject(s) - medicine , cystatin c , creatinine , kidney disease , renal function , disease

It remains uncertain whether cystatin C is a superior marker of renal function than creatinine in older adults. We have investigated the association between estimated glomerular filtration rate (eGFR) using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations based on creatinine (CKD-EPIcr) and cystatin C (CKD-EPIcys), and cardiovascular risk markers and mortality in older adults.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research